Medeloop
Menlo Park, US · Founded 2021 · Delaware corporation · 5 known investors
Medeloop develops AI agents that automate research and clinical analytics workflows for healthcare organizations. The platform enables users to answer epidemiological and clinical questions using patient data (EHRs, claims, registries) without coding, generating publication-ready evidence and supporting grant discovery, study management, and clinical care delivery.
AI & Machine LearningHealthtechMedical Devices
Founders & leadership
RC

Rene CaissieExecutive Officer, Director
JW
Joshua WalonoskiExecutive Officer
RS
Raghav SamavedamExecutive Officer
MC
Magaly CharbonneauDirector
AD
Amir Dan RubinDirector
EV
Elena VibochDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$15.5MraisedNov 2024 · 8 investors · OtherRule 506(b)
▶$15.5MraisedNov 2024 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Rene CaissieExecutive Officer, Director
- Magaly CharbonneauDirector
- Joshua WalonoskiExecutive Officer
- Amir Dan RubinDirector
- Raghav SamavedamExecutive Officer
- Elena VibochDirector
- Offering amount
- $17.5M
- Amount sold
- $15.5M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Medeloop: Medical Research Platform Company Raises $15.5 Million (Series A)pulse2.com · 2024
- Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Researchglobenewswire.com · 2024
- Medeloop Raises $8M in Seed Fundingfinsmes.com · 2023
- Pitch Deck Medeloop Used to Raise $8 Million From General Catalyst - Business Insiderbusinessinsider.com · 2023
- Medeloop Secures $8M Seed Funding to Pioneer the Future of Health Researchglobenewswire.com · 2023
- Medeloop Funding: $15.5M | Complete Analysis | Extruct AIextruct.ai